Eversept Partners »

Avalo Therapeutics Ord shares owned by Eversept Partners

Quarter-by-quarter ownership of Avalo Therapeutics Ord (AVTX) shares owned by Eversept Partners from 13F filings

Historical chart of Eversept Partners investment in Avalo Therapeutics Ord

Tip: Access up to 7 years of quarterly data

All positions including Avalo Therapeutics Ord held by Eversept Partners consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Avalo Therapeutics Ord by Eversept Partners

Quarter filed Position value Share count Share price at filing
2026-06-30 $185k 10k 18.48

More positions owned by Eversept Partners

United Therapeutics Corporation (UTHR)
Abivax Sa Sponsored Ads (ABVX)
Encompass Health Corp (EHC)
Ensign (ENSG)
Vera Therapeutics Cl A (VERA)
Invesco Qqq Tr Unit Ser 1 Put Option (QQQ)
Celldex Therapeutics Com New (CLDX)
Syndax Pharmaceuticals (SNDX)
Brookdale Senior Living (BKD)
Ionis Pharmaceuticals (IONS)
Natera (NTRA)
Travere Therapeutics (TVTX)
Caretrust Reit (CTRE)
Hca Holdings (HCA)
Vaxcyte (PCVX)

View all positions for Eversept Partners

Top funds holding Avalo Therapeutics Ord

FMR
BlackRock
Deep Track Capital
Caligan Partners
TCG Crossover Management
Affinity Asset Advisors
Farallon Capital Management
Point72 Asset Management
venBio Select Advisor
Vanguard Capital Management
BVF
Bank of America Corporation
Nantahala Capital Management
Adage Capital Partners GP
Soleus Capital Management

View all funds holding Avalo Therapeutics Ord